NEW YORK (GenomeWeb News) – Agilent Technologies and Strand Scientific Intelligence today announced an agreement to expand the scope of Agilent's GeneSpring bioinformatics system.
The agreement will increase utility of GeneSpring across multiple life science disciplines, drive future innovations, and "deliver new channels for accessing the software and customer support," the two companies said in a joint statement.
The agreement is expected to initially result in a version of GeneSpring that will allow researchers to do statistical analyses of and visualize data from genomic, metabolomics, and proteomics together "for the first time, using a familiar interface," they said. Strand's technology will be leveraged to enable integrated next-generation sequencing analysis abilities for GeneSpring users, they added.
As part of the agreement, a fully integrated portal for licensing, upgrading, and supporting the GeneSpring family of bioinformatics systems will be developed.
Agilent and Strand have worked together since August 2007. At the time Strand was developing Stratagene's ArrayAssist software. After Agilent acquired Stratagene, Agilent's GeneSping GX for gene expression was migrated to Strand's Avadis platform. All versions of GeneSpring have since been based on Avadis.
Francois Mandeville, Strand executive vice president, said in a statement, "Developing new scientific intelligence solutions that enable scientists to integrate, model, and visualize biological information is an important part of this new agreement, and we also look forward to going beyond this, developing new ways to deliver, customize, and support these solutions."
Financial terms of the deal were not announced.